Kipnes, M S <br/><br/>
Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.  [electronic resource] 

 -  The American journal of medicine  Jul 2001 
 - 10-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0002-9343 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9343(01)00713-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Blood Glucose--metabolism<br/>C-Peptide--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--blood<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Pioglitazone<br/>Sulfonylurea Compounds--administration & dosage<br/>Thiazoles--administration & dosage<br/>Thiazolidinediones<br/>Time Factors<br/>Treatment Outcome<br/>Triglycerides--blood<br/>United States